update from chrysalis: amivantamab in patients with nsclc with met exon 14 skipping mutation
Published 2 years ago • 822 plays • Length 3:01Download video MP4
Download video MP3
Similar videos
-
1:18
amivantamab for nsclc with met exon 14 skipping mutations
-
2:28
amivantamab in patients with egfr ex20ins-mutated nsclc
-
3:55
chrysalis trial update in nsclc
-
6:33
dr rushab kothari | amivantamab in nsclc patients with met exon 14 askipping mutation
-
1:02
investigating met exon 14 mutations in patients with nsclc
-
1:36
chrysalis: amivantamab for egfr exon 20 insertion mutant nsclc
-
6:13
vision: tepotinib in met exon 14 skipping nsclc
-
1:11
detecting the met exon 14 skipping mutations in nsclc
-
0:58
vision trial produces positive data in nsclc with met exon 14 mutations
-
2:03
amivantamab and lazertinib in treatment-naïve egfr-mutant nsclc
-
1:46
the evolving treatment landscape for nsclc with egfr exon 20 insertion mutations
-
1:22
gregory j. riely on the identification and treatment of patients with met exon 14 skipping mutations
-
1:06
gregory j. riely provides an overview of met exon 14 skipping mutations in lung cancer
-
4:27
amivantamab shows robust efficacy in post-platinum therapy patients with egfr ex20ins nsclc
-
2:40
dr. halmos on met mutations in patients with nsclc
-
1:17
updates on met targeted therapy for exon 14 mutations in lung cancer | oncotarget
-
0:49
the importance of metex14 testing in nsclc
-
4:14
crizotinib in patients with advanced met exon 14-altered nsclc
-
13:06
met exon 14 mutations in mnsclc